Release Date: 28/11/14 09:27 Summary: Acquisition of nSynergy and capital raising Price Sensitive: Yes Download Document 144.47KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%